DrugDashboards

Potassium Chloride

Potassium Chloride · POTASSIUM CHLORIDE 1500 mg/1 · Tablet, Film Coated, Extended Release · Oral · NCS HealthCare of KY, LLC dba Vangard Labs

NDC 00615-8580-05 · 15 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · ANDA · View full market →

The short version

22 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 70436-0153-01) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of saleⓘ
$0.2805per unit
middle half $0.1574–$0.3770 · 5,496 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $0.2805
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
100%of plans cover it
tier 2 · prior auth 0% · step therapy 0% · qty limit 0%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for potassium chloride (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $24.12 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Xywav and Xyrem

Regulatory

Application
ANDA212561
TE code
AB3
Approval date
Sep 30, 2019
Patents / exclusivity
None on file

Shortage history

  • Planned discontinuation — Klor-Con, Tablet, Extended Release, 600 mg (NDC 0245-5315-01)Jul 23, 2025
  • Planned discontinuation — Klor-Con, Tablet, Extended Release, 600 mg (NDC 0245-5315-11)Jul 23, 2025
  • Planned discontinuation — Klor-Con, Tablet, Extended Release, 600 mg (NDC 0245-5315-15)Jul 23, 2025
  • Planned discontinuation — Klor-Con, Tablet, Extended Release, 750 mg (NDC 0245-5316-01)Jul 23, 2025
  • Planned discontinuation — Klor-Con, Tablet, Extended Release, 750 mg (NDC 0245-5316-11)Jul 23, 2025
  • Planned discontinuation — Klor-Con, Tablet, Extended Release, 750 mg (NDC 0245-5316-15)Jul 23, 2025
  • Planned discontinuation — Potassium Chloride, Tablet, Extended Release, 600 mg (NDC 0832-5322-10)Jul 23, 2025
  • Planned discontinuation — Potassium Chloride, Tablet, Extended Release, 600 mg (NDC 0832-5322-11)Jul 23, 2025
  • Planned discontinuation — Potassium Chloride, Tablet, Extended Release, 750 mg (NDC 0832-5323-10)Jul 23, 2025
  • Planned discontinuation — Potassium Chloride, Tablet, Extended Release, 750 mg (NDC 0832-5323-11)Jul 23, 2025

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Potassium Chloride (Tablet, Film Coated, Extended Release)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 3, 2026
Aphena Pharma Solutions - Tennessee, LLCPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 3, 2026
Upsher-Smith Laboratories, LLCPOTASSIUM CHLORIDE 600 mg/1Jul 15, 2026Sep 3, 2026
Upsher-Smith Laboratories, LLCPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsPOTASSIUM CHLORIDE 10 meq/1Jul 15, 2026Sep 2, 2026
Advagen Pharma LtdPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Advagen Pharma LtdPOTASSIUM CHLORIDE 1125 mg/1Jul 15, 2026Sep 2, 2026
Advagen Pharma LtdPOTASSIUM CHLORIDE 1500 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedPOTASSIUM CHLORIDE 600 mg/1Jul 15, 2026Sep 2, 2026
AvKAREPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
BluePoint LaboratoriesPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackPOTASSIUM CHLORIDE 600 mg/1Jul 15, 2026Sep 2, 2026
Coupler LLCPOTASSIUM CHLORIDE 750 mg/1Aug 26, 2026Sep 2, 2026
Epic Pharma, LLCPOTASSIUM CHLORIDE 600 mg/1Jul 15, 2026Sep 2, 2026
Epic Pharma, LLCPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedPOTASSIUM CHLORIDE 600 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.POTASSIUM CHLORIDE 8 meq/1Jul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.POTASSIUM CHLORIDE 10 meq/1Jul 15, 2026Sep 2, 2026
NCS HealthCare of KY, LLC dba Vangard LabsPOTASSIUM CHLORIDE 1500 mg/1Jul 15, 2026Sep 2, 2026
NCS HealthCare of KY, LLC dba Vangard LabsPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
PD-Rx Pharmaceuticals, Inc.POTASSIUM CHLORIDE 1500 mg/1Jul 15, 2026Sep 2, 2026
PD-Rx Pharmaceuticals, Inc.POTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc.POTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.POTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Slate Run Pharmaceuticals, LLCPOTASSIUM CHLORIDE 600 mg/1Jul 15, 2026Sep 2, 2026
Slate Run Pharmaceuticals, LLCPOTASSIUM CHLORIDE 1500 mg/1Jul 15, 2026Sep 2, 2026
St. Mary's Medical Park PharmacyPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Northwind Health Company, LLCPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Aug 31, 2026
Slate Run Pharmaceuticals, LLCPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Potassium Chloride — NDC 00615-8580-05," retrieved September 3, 2026, https://drugdashboards.com/drug/00615858005.

Free to cite with attribution — see how the data is put together.